"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","description.1","description.2","description.3","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","data_processing.5","platform_id","contact_name","contact_email","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","disease status:ch1","endocrine cell-type:ch1","patient:ch1","population:ch1","tissue:ch1"
"GSM2574469","RHG1111_hg19_accepted_hits","GSM2574469","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710485","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733099","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574470","RHG1112_hg19_accepted_hits","GSM2574470","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710484","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733100","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574471","RHG1113_hg19_accepted_hits","GSM2574471","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710483","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733101","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574472","RHG1114_hg19_accepted_hits","GSM2574472","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710406","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733102","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574473","RHG1115_hg19_accepted_hits","GSM2574473","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710436","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733103","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574474","RHG1116_hg19_accepted_hits","GSM2574474","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710435","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733104","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574475","RHG1117_hg19_accepted_hits","GSM2574475","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710434","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733105","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574476","RHG1118_hg19_accepted_hits","GSM2574476","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710433","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733106","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574477","RHG1119_hg19_accepted_hits","GSM2574477","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710432","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733107","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574478","RHG1121_hg19_accepted_hits","GSM2574478","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710431","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733108","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574479","RHG1123_hg19_accepted_hits","GSM2574479","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710430","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733109","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574480","RHG1125_hg19_accepted_hits","GSM2574480","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710429","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733110","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574481","RHG1127_hg19_accepted_hits","GSM2574481","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710428","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733111","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574482","RHG1129_hg19_accepted_hits","GSM2574482","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710427","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733112","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574483","RHG1130_hg19_accepted_hits","GSM2574483","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710426","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733113","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574484","RHG1131_hg19_accepted_hits","GSM2574484","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710425","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733114","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574485","RHG1133_hg19_accepted_hits","GSM2574485","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710423","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733115","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574486","RHG1135_hg19_accepted_hits","GSM2574486","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710422","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733116","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574487","RHG1139_hg19_accepted_hits","GSM2574487","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710421","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733117","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574488","RHG1142_hg19_accepted_hits","GSM2574488","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710420","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733118","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574489","RHG1143_hg19_accepted_hits","GSM2574489","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710419","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733119","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574490","RHG1144_hg19_accepted_hits","GSM2574490","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710418","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733120","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574491","RHG1145_hg19_accepted_hits","GSM2574491","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710424","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733121","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574492","RHG1146_hg19_accepted_hits","GSM2574492","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710417","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733122","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574493","RHG1147_hg19_accepted_hits","GSM2574493","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710416","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733123","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574494","RHG1148_hg19_accepted_hits","GSM2574494","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710415","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733124","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574495","RHG1149_hg19_accepted_hits","GSM2574495","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710414","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733125","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574496","RHG1150_hg19_accepted_hits","GSM2574496","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710413","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733126","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574497","RHG1157_hg19_accepted_hits","GSM2574497","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710412","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733127","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574498","RHG1158_hg19_accepted_hits","GSM2574498","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710411","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733128","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574499","RHG1161_hg19_accepted_hits","GSM2574499","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710410","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733129","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574500","RHG1162_hg19_accepted_hits","GSM2574500","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710409","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733130","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574501","RHG1164_hg19_accepted_hits","GSM2574501","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710408","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733131","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574502","RHG1165_hg19_accepted_hits","GSM2574502","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710407","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733132","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574503","RHG1168_hg19_accepted_hits","GSM2574503","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710482","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733133","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574504","RHG1175_hg19_accepted_hits","GSM2574504","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710481","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733134","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574505","RHG1177_hg19_accepted_hits","GSM2574505","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710480","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733135","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574506","RHG1178_hg19_accepted_hits","GSM2574506","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710479","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733136","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574507","RHG1181_hg19_accepted_hits","GSM2574507","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710478","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733137","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574508","RHG1185_hg19_accepted_hits","GSM2574508","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710477","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733138","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574509","RHG1189_hg19_accepted_hits","GSM2574509","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710476","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733139","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574510","RHG1190_hg19_accepted_hits","GSM2574510","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710475","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733140","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574511","RHG1194_hg19_accepted_hits","GSM2574511","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710474","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733141","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574512","RHG1197_hg19_accepted_hits","GSM2574512","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710473","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733142","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574513","RHG1199_hg19_accepted_hits","GSM2574513","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710472","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733143","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574514","RHG1201_hg19_accepted_hits","GSM2574514","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710471","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733144","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574515","RHG1202_hg19_accepted_hits","GSM2574515","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710470","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733145","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574516","RHG1205_hg19_accepted_hits","GSM2574516","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710469","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733146","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574517","RHG1206_hg19_accepted_hits","GSM2574517","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710468","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733147","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574518","RHG1208_hg19_accepted_hits","GSM2574518","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710467","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733148","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574519","RHG1209_hg19_accepted_hits","GSM2574519","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710466","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733149","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574520","RHG1213_hg19_accepted_hits","GSM2574520","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710465","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733150","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574521","RHG1215_hg19_accepted_hits","GSM2574521","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710464","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733151","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574522","RHG1217_hg19_accepted_hits","GSM2574522","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710463","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733152","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574523","RHG1220_hg19_accepted_hits","GSM2574523","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710462","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733153","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574524","RHG1221_hg19_accepted_hits","GSM2574524","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710461","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733154","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574525","RHG1222_hg19_accepted_hits","GSM2574525","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710460","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733155","NONE","Non-diabetic","Beta","1","East-Asian","Pancreatic islet"
"GSM2574526","RHG1224_hg19_accepted_hits","GSM2574526","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710459","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733156","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574527","RHG1226_hg19_accepted_hits","GSM2574527","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710458","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733157","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574528","RHG1230_hg19_accepted_hits","GSM2574528","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710457","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733158","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574529","RHG1236_hg19_accepted_hits","GSM2574529","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710456","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733159","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574530","RHG1238_hg19_accepted_hits","GSM2574530","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710455","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733160","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574531","RHG1244_hg19_accepted_hits","GSM2574531","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710454","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733161","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574532","RHG1246_hg19_accepted_hits","GSM2574532","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710453","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733162","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574533","RHG1247_hg19_accepted_hits","GSM2574533","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 1","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710380","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733163","NONE","Non-diabetic","Alpha","1","East-Asian","Pancreatic islet"
"GSM2574534","RHG1251_hg19_accepted_hits","GSM2574534","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710379","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733164","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574535","RHG1256_hg19_accepted_hits","GSM2574535","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710378","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733165","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574536","RHG1257_hg19_accepted_hits","GSM2574536","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710377","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733166","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574537","RHG1258_hg19_accepted_hits","GSM2574537","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710376","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733167","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574538","RHG1259_hg19_accepted_hits","GSM2574538","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710375","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733168","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574539","RHG1260_hg19_accepted_hits","GSM2574539","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710374","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733169","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574540","RHG1261_hg19_accepted_hits","GSM2574540","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710373","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733170","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574541","RHG1262_hg19_accepted_hits","GSM2574541","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710372","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733171","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574542","RHG1264_hg19_accepted_hits","GSM2574542","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710371","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733172","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574543","RHG1265_hg19_accepted_hits","GSM2574543","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710370","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733173","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574544","RHG1266_hg19_accepted_hits","GSM2574544","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710369","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733174","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574545","RHG1267_hg19_accepted_hits","GSM2574545","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710368","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733175","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574546","RHG1268_hg19_accepted_hits","GSM2574546","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710367","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733176","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574547","RHG1269_hg19_accepted_hits","GSM2574547","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710366","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733177","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574548","RHG1271_hg19_accepted_hits","GSM2574548","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710365","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733178","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574549","RHG1273_hg19_accepted_hits","GSM2574549","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710364","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733179","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574550","RHG1276_hg19_accepted_hits","GSM2574550","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710363","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733180","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574551","RHG1277_hg19_accepted_hits","GSM2574551","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710356","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733181","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574552","RHG1278_hg19_accepted_hits","GSM2574552","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710362","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733182","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574553","RHG1280_hg19_accepted_hits","GSM2574553","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710361","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733183","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574554","RHG1282_hg19_accepted_hits","GSM2574554","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710360","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733184","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574555","RHG1283_hg19_accepted_hits","GSM2574555","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710359","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733185","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574556","RHG1284_hg19_accepted_hits","GSM2574556","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710358","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733186","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574557","RHG1285_hg19_accepted_hits","GSM2574557","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710357","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733187","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574558","RHG1288_hg19_accepted_hits","GSM2574558","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710355","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733188","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574559","RHG1289_hg19_accepted_hits","GSM2574559","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710354","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733189","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574560","RHG1291_hg19_accepted_hits","GSM2574560","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710353","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733190","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574561","RHG1292_hg19_accepted_hits","GSM2574561","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710352","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733191","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574562","RHG1293_hg19_accepted_hits","GSM2574562","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710351","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733192","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574563","RHG1295_hg19_accepted_hits","GSM2574563","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710350","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733193","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574564","RHG1296_hg19_accepted_hits","GSM2574564","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710349","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733194","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574565","RHG1297_hg19_accepted_hits","GSM2574565","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710348","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733195","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574566","RHG1302_hg19_accepted_hits","GSM2574566","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710347","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733196","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574567","RHG1303_hg19_accepted_hits","GSM2574567","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710346","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733197","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574568","RHG1306_hg19_accepted_hits","GSM2574568","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710345","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733198","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574569","RHG1307_hg19_accepted_hits","GSM2574569","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710344","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733199","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574570","RHG1309_hg19_accepted_hits","GSM2574570","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710343","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733200","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574571","RHG1310_hg19_accepted_hits","GSM2574571","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710342","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733201","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574572","RHG1314_hg19_accepted_hits","GSM2574572","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710341","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733202","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574573","RHG1315_hg19_accepted_hits","GSM2574573","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710340","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733203","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574574","RHG1316_hg19_accepted_hits","GSM2574574","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710339","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733204","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574575","RHG1319_hg19_accepted_hits","GSM2574575","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710338","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733205","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574576","RHG1320_hg19_accepted_hits","GSM2574576","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710337","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733206","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574577","RHG1321_hg19_accepted_hits","GSM2574577","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710336","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733207","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574578","RHG1323_hg19_accepted_hits","GSM2574578","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710335","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733208","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574579","RHG1325_hg19_accepted_hits","GSM2574579","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710334","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733209","NONE","Non-diabetic","Beta","2","East-Asian","Pancreatic islet"
"GSM2574580","RHG1331_hg19_accepted_hits","GSM2574580","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710333","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733210","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574581","RHG1333_hg19_accepted_hits","GSM2574581","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 2","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710332","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733211","NONE","Non-diabetic","Alpha","2","East-Asian","Pancreatic islet"
"GSM2574582","RHG1335_hg19_accepted_hits","GSM2574582","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710331","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733212","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574583","RHG1336_hg19_accepted_hits","GSM2574583","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710330","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733213","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574584","RHG1337_hg19_accepted_hits","GSM2574584","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710329","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733214","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574585","RHG1341_hg19_accepted_hits","GSM2574585","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710328","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733215","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574586","RHG1342_hg19_accepted_hits","GSM2574586","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710327","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733216","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574587","RHG1344_hg19_accepted_hits","GSM2574587","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710326","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733217","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574588","RHG1346_hg19_accepted_hits","GSM2574588","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710325","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733218","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574589","RHG1350_hg19_accepted_hits","GSM2574589","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710440","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733219","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574590","RHG1351_hg19_accepted_hits","GSM2574590","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710439","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733220","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574591","RHG1353_hg19_accepted_hits","GSM2574591","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710438","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733221","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574592","RHG1354_hg19_accepted_hits","GSM2574592","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710437","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733222","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574593","RHG1356_hg19_accepted_hits","GSM2574593","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710405","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733223","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574594","RHG1358_hg19_accepted_hits","GSM2574594","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710404","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733224","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574595","RHG1361_hg19_accepted_hits","GSM2574595","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710403","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733225","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574596","RHG1362_hg19_accepted_hits","GSM2574596","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710402","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733226","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574597","RHG1365_hg19_accepted_hits","GSM2574597","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710401","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733227","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574598","RHG1366_hg19_accepted_hits","GSM2574598","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710400","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733228","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574599","RHG1367_hg19_accepted_hits","GSM2574599","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710399","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733229","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574600","RHG1369_hg19_accepted_hits","GSM2574600","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710398","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733230","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574601","RHG1370_hg19_accepted_hits","GSM2574601","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710397","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733231","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574602","RHG1371_hg19_accepted_hits","GSM2574602","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710396","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733232","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574603","RHG1372_hg19_accepted_hits","GSM2574603","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710395","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733233","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574604","RHG1373_hg19_accepted_hits","GSM2574604","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710394","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733234","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574605","RHG1374_hg19_accepted_hits","GSM2574605","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710393","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733235","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574606","RHG1381_hg19_accepted_hits","GSM2574606","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710392","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733236","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574607","RHG1384_hg19_accepted_hits","GSM2574607","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710391","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733237","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574608","RHG1385_hg19_accepted_hits","GSM2574608","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710390","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733238","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574609","RHG1386_hg19_accepted_hits","GSM2574609","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710389","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733239","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574610","RHG1387_hg19_accepted_hits","GSM2574610","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710388","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733240","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574611","RHG1388_hg19_accepted_hits","GSM2574611","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710387","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733241","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574612","RHG1389_hg19_accepted_hits","GSM2574612","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710386","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733242","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574613","RHG1391_hg19_accepted_hits","GSM2574613","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710385","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733243","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574614","RHG1393_hg19_accepted_hits","GSM2574614","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710384","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733244","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574615","RHG1394_hg19_accepted_hits","GSM2574615","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710383","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733245","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574616","RHG1395_hg19_accepted_hits","GSM2574616","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710492","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733246","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574617","RHG1396_hg19_accepted_hits","GSM2574617","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710491","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733247","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574618","RHG1398_hg19_accepted_hits","GSM2574618","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710490","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733248","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574619","RHG1401_hg19_accepted_hits","GSM2574619","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710489","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733249","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574620","RHG1402_hg19_accepted_hits","GSM2574620","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710488","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733250","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574621","RHG1404_hg19_accepted_hits","GSM2574621","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710487","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733251","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574622","RHG1405_hg19_accepted_hits","GSM2574622","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710486","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733252","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574623","RHG1409_hg19_accepted_hits","GSM2574623","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710452","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733253","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574624","RHG1410_hg19_accepted_hits","GSM2574624","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710451","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733254","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574625","RHG1412_hg19_accepted_hits","GSM2574625","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710450","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733255","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574626","RHG1413_hg19_accepted_hits","GSM2574626","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710449","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733256","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574627","RHG1414_hg19_accepted_hits","GSM2574627","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710448","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733257","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574628","RHG1415_hg19_accepted_hits","GSM2574628","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710447","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733258","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574629","RHG1416_hg19_accepted_hits","GSM2574629","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710446","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733259","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574630","RHG1417_hg19_accepted_hits","GSM2574630","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710496","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733260","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574631","RHG1419_hg19_accepted_hits","GSM2574631","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710495","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733261","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574632","RHG1420_hg19_accepted_hits","GSM2574632","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710272","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733262","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574633","RHG1421_hg19_accepted_hits","GSM2574633","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710445","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733263","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574634","RHG1423_hg19_accepted_hits","GSM2574634","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710444","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733264","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574635","RHG1424_hg19_accepted_hits","GSM2574635","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710443","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733265","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574636","RHG1428_hg19_accepted_hits","GSM2574636","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710442","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733266","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574637","RHG1429_hg19_accepted_hits","GSM2574637","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710441","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733267","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574638","RHG1430_hg19_accepted_hits","GSM2574638","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710324","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733268","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574639","RHG1431_hg19_accepted_hits","GSM2574639","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710323","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733269","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574640","RHG1432_hg19_accepted_hits","GSM2574640","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710322","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733270","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574641","RHG1433_hg19_accepted_hits","GSM2574641","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710321","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733271","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574642","RHG1436_hg19_accepted_hits","GSM2574642","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710320","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733272","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574643","RHG1437_hg19_accepted_hits","GSM2574643","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710319","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733273","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574644","RHG1438_hg19_accepted_hits","GSM2574644","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710318","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733274","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574645","RHG1446_hg19_accepted_hits","GSM2574645","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710317","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733275","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574646","RHG1449_hg19_accepted_hits","GSM2574646","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710316","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733276","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574647","RHG1451_hg19_accepted_hits","GSM2574647","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710315","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733277","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574648","RHG1452_hg19_accepted_hits","GSM2574648","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710314","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733278","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574649","RHG1453_hg19_accepted_hits","GSM2574649","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710313","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733279","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574650","RHG1454_hg19_accepted_hits","GSM2574650","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710312","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733280","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574651","RHG1456_hg19_accepted_hits","GSM2574651","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710311","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733281","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574652","RHG1457_hg19_accepted_hits","GSM2574652","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710310","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733282","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574653","RHG1459_hg19_accepted_hits","GSM2574653","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710309","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733283","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574654","RHG1461_hg19_accepted_hits","GSM2574654","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710308","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733284","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574655","RHG1462_hg19_accepted_hits","GSM2574655","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710307","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733285","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574656","RHG1470_hg19_accepted_hits","GSM2574656","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710306","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733286","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574657","RHG1471_hg19_accepted_hits","GSM2574657","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710305","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733287","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574658","RHG1472_hg19_accepted_hits","GSM2574658","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710304","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733288","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574659","RHG1474_hg19_accepted_hits","GSM2574659","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710303","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733289","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574660","RHG1475_hg19_accepted_hits","GSM2574660","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710302","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733290","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574661","RHG1476_hg19_accepted_hits","GSM2574661","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710301","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733291","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574662","RHG1478_hg19_accepted_hits","GSM2574662","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710300","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733292","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574663","RHG1482_hg19_accepted_hits","GSM2574663","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710299","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733293","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574664","RHG1485_hg19_accepted_hits","GSM2574664","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710298","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733294","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574665","RHG1487_hg19_accepted_hits","GSM2574665","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710297","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733295","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574666","RHG1488_hg19_accepted_hits","GSM2574666","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710296","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733296","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574667","RHG1490_hg19_accepted_hits","GSM2574667","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710295","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733297","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574668","RHG1497_hg19_accepted_hits","GSM2574668","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710294","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733298","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574669","RHG1499_hg19_accepted_hits","GSM2574669","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710293","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733299","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574670","RHG1513_hg19_accepted_hits","GSM2574670","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710292","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733300","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574671","RHG1515_hg19_accepted_hits","GSM2574671","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710291","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733301","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574672","RHG1519_hg19_accepted_hits","GSM2574672","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710290","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733302","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574673","RHG1520_hg19_accepted_hits","GSM2574673","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710289","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733303","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574674","RHG1521_hg19_accepted_hits","GSM2574674","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710288","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733304","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574675","RHG1522_hg19_accepted_hits","GSM2574675","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710287","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733305","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574676","RHG1524_hg19_accepted_hits","GSM2574676","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710286","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733306","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574677","RHG1526_hg19_accepted_hits","GSM2574677","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710285","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733307","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574678","RHG1527_hg19_accepted_hits","GSM2574678","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710284","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733308","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574679","RHG1528_hg19_accepted_hits","GSM2574679","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710283","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733309","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574680","RHG1537_hg19_accepted_hits","GSM2574680","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710282","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733310","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574681","RHG1539_hg19_accepted_hits","GSM2574681","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710281","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733311","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574682","RHG1542_hg19_accepted_hits","GSM2574682","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710280","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733312","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574683","RHG1544_hg19_accepted_hits","GSM2574683","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710279","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733313","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574684","RHG1549_hg19_accepted_hits","GSM2574684","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710278","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733314","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574685","RHG1550_hg19_accepted_hits","GSM2574685","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710277","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733315","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574686","RHG1551_hg19_accepted_hits","GSM2574686","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710276","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733316","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574687","RHG1554_hg19_accepted_hits","GSM2574687","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, alpha cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Alpha","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710275","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733317","NONE","Non-diabetic","Alpha","3","East-Asian","Pancreatic islet"
"GSM2574688","RHG1556_hg19_accepted_hits","GSM2574688","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710274","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733318","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574689","RHG1558_hg19_accepted_hits","GSM2574689","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710273","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733319","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574690","RHG1561_hg19_accepted_hits","GSM2574690","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710382","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733320","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
"GSM2574691","RHG1563_hg19_accepted_hits","GSM2574691","Public on Aug 11 2017","Apr 11 2017","May 15 2019","SRA","1","Pancreatic islet, beta cell","Homo sapiens","patient: 3","population: East-Asian","disease status: Non-diabetic","tissue: Pancreatic islet","endocrine cell-type: Beta","total RNA","Single cells were processed for RNA-seq using Nextera XT kits (Illumina). Cell lysis, reverse transcription (SMARTer Ultra Low RNA kit, Clontech) and PCR amplification (Advantage® 2 kit, Clontech) were performed on the C1™ Auto-prep module.","Approximately 0.15 ng of cDNA from each cell was processed for RNA-seq using Nextera XT DNA library preparation kits (Illumina).","9606","PolyA RNA","scRNA-seq","Processed data file: 293alphaandbetacells.txt","The paired-end raw data files are loaded at SRA as single-end files.","Illumina HiSeq 4000 reads were trimmed and clipped for quality control in Trimmomatic.","Read quality was checked for each sample using FastQC.","High-quality reads were then imported into TopHat v2.0.8 for alignment into BAM files.","BAM files were imported into the RNA-Seq pipeline of Partek Genomics Suite, version 6.6, and RPKM counts were calculated (RefSeq release 2016-8-1). Inclusion included a minimum RPKM value of 50.0 in at least 25% of cells. RPKM values were quantile normalized.","Genome_build: hg19","Supplementary_files_format_and_content: 293alphaandbetacells.txt: Tab-delimited text file includes normalized RPKM values for each sample.","GPL20301","Rajkumar,,Dorajoo","dorajoor@gis.a-star.edu.sg","Genome Institute of Singapore","60 Biopolis Street","Singapore","138672","Singapore","0","Illumina HiSeq 4000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06710381","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2733321","NONE","Non-diabetic","Beta","3","East-Asian","Pancreatic islet"
